Breaking News Instant updates and real-time market news.

COLD

Americold Realty Trust

$30.99 /

-0.58 (-1.84%)

06:52
07/07/22
07/07
06:52
07/07/22
06:52

Americold Realty Trust price target raised to $33 from $29 at Baird

Baird analyst David Rodgers raised the firm's price target on Americold Realty Trust to $33 from $29 and keeps an Outperform rating on the shares. The analyst raised his 2022/2023 AFFO estimates and increased his fair value outlook and while he thinks a full recovery could take several years, his prior outlook now appears conservative.

  • 04

    Aug

OTHER BREAKING NEWS FROM THE FLY

Recommendations
Karuna Therapeutics price target raised to $261 from $160 at BofA » 06:25
08/09/22
08/09
06:25
08/09/22
06:25
KRTX

Karuna Therapeutics

$241.52 /

+101.41 (+72.38%)

BofA analyst Jason…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KRTX Karuna Therapeutics
$241.52 /

+101.41 (+72.38%)

KRTX Karuna Therapeutics
$241.52 /

+101.41 (+72.38%)

08/08/22 Stifel
Cerevel Therapeutics price target raised to $54 from $50 at Stifel
08/08/22 Stifel
Karuna Therapeutics price target raised to $260 from $185 at Stifel
08/08/22 JMP Securities
Karuna Therapeutics price target raised to $315 from $190 at JMP Securities
08/08/22 Citi
Karuna Therapeutics price target raised to $280 from $162 at Citi
KRTX Karuna Therapeutics
$241.52 /

+101.41 (+72.38%)

  • 10
    Aug
  • 10
    Nov
KRTX Karuna Therapeutics
$241.52 /

+101.41 (+72.38%)

Recommendations
Aurinia Pharmaceuticals price target lowered to $26 from $30 at H.C. Wainwright » 06:24
08/09/22
08/09
06:24
08/09/22
06:24
AUPH

Aurinia Pharmaceuticals

$8.28 /

-0.075 (-0.90%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AUPH Aurinia Pharmaceuticals
$8.28 /

-0.075 (-0.90%)

AUPH Aurinia Pharmaceuticals
$8.28 /

-0.075 (-0.90%)

05/05/22 Cantor Fitzgerald
Aurinia Pharmaceuticals assumed with an Overweight at Cantor Fitzgerald
05/04/22 H.C. Wainwright
Aurinia Pharmaceuticals price target lowered to $30 from $33 at H.C. Wainwright
04/28/22 RBC Capital
Aurinia Pharmaceuticals price target lowered to $22 from $27 at RBC Capital
03/01/22 RBC Capital
Aurinia Pharmaceuticals price target lowered to $27 from $31 at RBC Capital
AUPH Aurinia Pharmaceuticals
$8.28 /

-0.075 (-0.90%)

AUPH Aurinia Pharmaceuticals
$8.28 /

-0.075 (-0.90%)

AUPH Aurinia Pharmaceuticals
$8.28 /

-0.075 (-0.90%)

AUPH Aurinia Pharmaceuticals
$8.28 /

-0.075 (-0.90%)

Recommendations
Pliant Therapeutics price target raised to $53 from $45 at H.C. Wainwright » 06:24
08/09/22
08/09
06:24
08/09/22
06:24
PLRX

Pliant Therapeutics

$18.95 /

+0.04 (+0.21%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PLRX Pliant Therapeutics
$18.95 /

+0.04 (+0.21%)

PLRX Pliant Therapeutics
$18.95 /

+0.04 (+0.21%)

07/26/22 Cantor Fitzgerald
Pliant Therapeutics price target raised to $40 from $36 at Cantor Fitzgerald
07/20/22 SVB Securities
Pliant Therapeutics initiated with an Outperform at SVB Securities
07/11/22 Piper Sandler
Pliant Therapeutics price target raised to $40 from $27 at Piper Sandler
07/11/22 Cantor Fitzgerald
Pliant Therapeutics price target raised to $36 from $28 at Cantor Fitzgerald
PLRX Pliant Therapeutics
$18.95 /

+0.04 (+0.21%)

  • 13
    Jul
PLRX Pliant Therapeutics
$18.95 /

+0.04 (+0.21%)

PLRX Pliant Therapeutics
$18.95 /

+0.04 (+0.21%)

Syndicate
PennantPark Floating Rate 4M share Spot Secondary priced at $12.40 » 06:23
08/09/22
08/09
06:23
08/09/22
06:23
PFLT

PennantPark Floating Rate

$13.21 /

+0.3 (+2.32%)

The deal range was…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PFLT PennantPark Floating Rate
$13.21 /

+0.3 (+2.32%)

PFLT PennantPark Floating Rate
$13.21 /

+0.3 (+2.32%)

08/09/21 Ladenburg
PennantPark Floating Rate downgraded to Neutral at Ladenburg
08/09/21 Ladenburg
PennantPark Floating Rate downgraded to Neutral from Buy at Ladenburg
PFLT PennantPark Floating Rate
$13.21 /

+0.3 (+2.32%)

  • 09
    Aug
Recommendations
Acadia Pharmaceuticals price target raised to $25 from $20 at H.C. Wainwright » 06:23
08/09/22
08/09
06:23
08/09/22
06:23
ACAD

Acadia Pharmaceuticals

$16.65 /

+0.225 (+1.37%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ACAD Acadia Pharmaceuticals
$16.65 /

+0.225 (+1.37%)

ACAD Acadia Pharmaceuticals
$16.65 /

+0.225 (+1.37%)

05:40 Today Citi
Acadia Pharmaceuticals price target raised to $17 from $15 at Citi
08/08/22 Cowen
Acadia Pharmaceuticals price target lowered to $21 from $32 at Cowen
08/05/22 Citi
Acadia Pharmaceuticals downgraded to Neutral from Buy at Citi
06/22/22 Canaccord
Acadia Pharmaceuticals price target lowered to $20 from $31 at Canaccord
ACAD Acadia Pharmaceuticals
$16.65 /

+0.225 (+1.37%)

ACAD Acadia Pharmaceuticals
$16.65 /

+0.225 (+1.37%)

ACAD Acadia Pharmaceuticals
$16.65 /

+0.225 (+1.37%)

Recommendations
PubMatic price target lowered to $34 from $40 at JMP Securities » 06:23
08/09/22
08/09
06:23
08/09/22
06:23
PUBM

PubMatic

$17.81 /

+0.365 (+2.09%)

JMP Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PUBM PubMatic
$17.81 /

+0.365 (+2.09%)

PUBM PubMatic
$17.81 /

+0.365 (+2.09%)

08/04/22 Jefferies
PubMatic price target lowered to $20 from $23 at Jefferies
08/01/22 KeyBanc
PubMatic downgraded to Sector Weight from Overweight at KeyBanc
07/27/22 KeyBanc
Google's cookie phase-out delay not surprising, says KeyBanc
07/27/22 RBC Capital
Google cookie phase-out delay adds another year of uncertainty, says RBC Capital
PUBM PubMatic
$17.81 /

+0.365 (+2.09%)

PUBM PubMatic
$17.81 /

+0.365 (+2.09%)

PUBM PubMatic
$17.81 /

+0.365 (+2.09%)

Hot Stocks
Village Farms announces Leli Holland been granted tenth cannabis license » 06:23
08/09/22
08/09
06:23
08/09/22
06:23
VFF

Village Farms

$3.13 /

-0.06 (-1.88%)

Village Farms announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VFF Village Farms
$3.13 /

-0.06 (-1.88%)

VFF Village Farms
$3.13 /

-0.06 (-1.88%)

05/11/22 Craig-Hallum
Village Farms price target lowered to $5 from $15 at Craig-Hallum
05/11/22 Raymond James
Village Farms downgraded to Outperform from Strong Buy at Raymond James
05/10/22 Alliance Global Partners
Village Farms price target lowered to $10 from $17 at Alliance Global Partners
03/03/22 Stifel
Village Farms downgraded to Hold from Buy at Stifel
VFF Village Farms
$3.13 /

-0.06 (-1.88%)

Recommendations
uniQure selloff brings attractive entry point, says H.C. Wainwright » 06:21
08/09/22
08/09
06:21
08/09/22
06:21
QURE

uniQure

$18.60 /

-6.92 (-27.12%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
QURE uniQure
$18.60 /

-6.92 (-27.12%)

QURE uniQure
$18.60 /

-6.92 (-27.12%)

08/08/22 Chardan
uniQure price target lowered to $60 from $65 at Chardan
08/08/22 Truist
uniQure's high-dose HD data still on track for 1H23, says Truist
05/05/22 Stifel
uniQure price target lowered to $37 from $66 at Stifel
04/13/22 Truist
uniQure price target lowered to $51 from $90 at Truist
QURE uniQure
$18.60 /

-6.92 (-27.12%)

QURE uniQure
$18.60 /

-6.92 (-27.12%)

Earnings
Village Farms reports Q2 EPS (41c) vs. (13c) last year » 06:21
08/09/22
08/09
06:21
08/09/22
06:21
VFF

Village Farms

$3.13 /

-0.06 (-1.88%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VFF Village Farms
$3.13 /

-0.06 (-1.88%)

VFF Village Farms
$3.13 /

-0.06 (-1.88%)

05/11/22 Craig-Hallum
Village Farms price target lowered to $5 from $15 at Craig-Hallum
05/11/22 Raymond James
Village Farms downgraded to Outperform from Strong Buy at Raymond James
05/10/22 Alliance Global Partners
Village Farms price target lowered to $10 from $17 at Alliance Global Partners
03/03/22 Stifel
Village Farms downgraded to Hold from Buy at Stifel
VFF Village Farms
$3.13 /

-0.06 (-1.88%)

General news
European stock markets are narrowly mixed, » 06:20
08/09/22
08/09
06:20
08/09/22
06:20
$ECON

Economic Data

/

+

European stock markets…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

General news
U.S. productivity preview » 06:20
08/09/22
08/09
06:20
08/09/22
06:20
$ECON

Economic Data

/

+

U.S. productivity…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

Upgrade
Myovant Sciences upgraded to Outperform from Market Perform at SVB Securities » 06:19
08/09/22
08/09
06:19
08/09/22
06:19
MYOV

Myovant Sciences

/

+

SVB Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MYOV Myovant Sciences
/

+

MYOV Myovant Sciences
/

+

06:11 Today SVB Securities
Myovant Sciences upgraded to Outperform from Market Perform at SVB Securities
04/13/22 Baird
Myovant Sciences price target lowered to $20 from $30 at Baird
09/09/21 SVB Leerink
SVB Leerink starts Myovant at Market Perform
09/09/21 SVB Leerink
Myovant Sciences initiated with a Market Perform at SVB Leerink
MYOV Myovant Sciences
/

+

MYOV Myovant Sciences
/

+

Recommendations
Precigen price target lowered to $6 from $10 at H.C. Wainwright » 06:19
08/09/22
08/09
06:19
08/09/22
06:19
PGEN

Precigen

$2.07 /

-0.01 (-0.48%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PGEN Precigen
$2.07 /

-0.01 (-0.48%)

PGEN Precigen
$2.07 /

-0.01 (-0.48%)

07/05/22 Stifel
Precigen subsidiary sale relieves convertible debt overhang, says Stifel
PGEN Precigen
$2.07 /

-0.01 (-0.48%)

Recommendations
SpringsWorks Therapeutics price target lowered to $94 from $95 at H.C. Wainwright » 06:18
08/09/22
08/09
06:18
08/09/22
06:18
SWTX

SpringsWorks Therapeutics

$39.68 /

+2.825 (+7.67%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SWTX SpringsWorks Therapeutics
$39.68 /

+2.825 (+7.67%)

SWTX SpringsWorks Therapeutics
$39.68 /

+2.825 (+7.67%)

06/06/22 H.C. Wainwright
SpringsWorks price target lowered to $95 from $142 at H.C. Wainwright
06/06/22 H.C. Wainwright
Turning Point Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
05/27/22 Wedbush
SpringsWorks Therapeutics price target lowered to $50 from $110 at Wedbush
05/24/22 Goldman Sachs
SpringsWorks Therapeutics price target raised to $82 from $76 at Goldman Sachs
SWTX SpringsWorks Therapeutics
$39.68 /

+2.825 (+7.67%)

SWTX SpringsWorks Therapeutics
$39.68 /

+2.825 (+7.67%)

Hot Stocks
Huntsman to sell Textile Effects division to Archroma for $718M » 06:18
08/09/22
08/09
06:18
08/09/22
06:18
HUN

Huntsman

$29.26 /

+0.34 (+1.18%)

Huntsman announced it has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HUN Huntsman
$29.26 /

+0.34 (+1.18%)

HUN Huntsman
$29.26 /

+0.34 (+1.18%)

08/04/22 Citi
Huntsman price target lowered to $34 from $35 at Citi
08/03/22 Deutsche Bank
Huntsman price target lowered to $35 from $40 at Deutsche Bank
07/25/22 UBS
Huntsman downgraded to Neutral from Buy at UBS
06/22/22 Wells Fargo
Huntsman price target lowered to $35 from $42 at Wells Fargo
HUN Huntsman
$29.26 /

+0.34 (+1.18%)

HUN Huntsman
$29.26 /

+0.34 (+1.18%)

HUN Huntsman
$29.26 /

+0.34 (+1.18%)

Recommendations
Relay Therapeutics price target lowered to $46 from $47 at H.C. Wainwright » 06:18
08/09/22
08/09
06:18
08/09/22
06:18
RLAY

Relay Therapeutics

$19.85 /

+0.15 (+0.76%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RLAY Relay Therapeutics
$19.85 /

+0.15 (+0.76%)

06/06/22 Jefferies
Relay Therapeutics initiated with an Underperform at Jefferies
05/10/22 H.C. Wainwright
Relay Therapeutics price target lowered to $47 from $54 at H.C. Wainwright
05/09/22 JMP Securities
Relay Therapeutics price target lowered to $35 from $50 at JMP Securities
02/01/22 Berenberg
Relay Therapeutics initiated with a Buy at Berenberg
RLAY Relay Therapeutics
$19.85 /

+0.15 (+0.76%)

  • 13
    Oct
Upgrade
Inspirato upgraded to Overweight from Neutral at Cantor Fitzgerald » 06:17
08/09/22
08/09
06:17
08/09/22
06:17
ISPO

Inspirato

$4.93 /

-0.11 (-2.18%)

Cantor Fitzgerald analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ISPO Inspirato
$4.93 /

-0.11 (-2.18%)

ISPO Inspirato
$4.93 /

-0.11 (-2.18%)

08/08/22 Piper Sandler
Inspirato price target lowered to $7 from $9 at Piper Sandler
07/22/22 Cantor Fitzgerald
Inspirato assumed with a Neutral at Cantor Fitzgerald
06/28/22 Stifel
Inspirato price target lowered to $6 from $7 at Stifel
06/14/22 Oppenheimer
Inspirato initiated with a Perform at Oppenheimer
ISPO Inspirato
$4.93 /

-0.11 (-2.18%)

ISPO Inspirato
$4.93 /

-0.11 (-2.18%)

ISPO Inspirato
$4.93 /

-0.11 (-2.18%)

Initiation
Finch Therapeutics initiated with a Buy at H.C. Wainwright » 06:17
08/09/22
08/09
06:17
08/09/22
06:17
FNCH

Finch Therapeutics

$2.47 /

+0.22 (+9.78%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FNCH Finch Therapeutics
$2.47 /

+0.22 (+9.78%)

FNCH Finch Therapeutics
$2.47 /

+0.22 (+9.78%)

04/04/22 Jefferies
Finch Therapeutics price target lowered to $17 from $29 at Jefferies
FNCH Finch Therapeutics
$2.47 /

+0.22 (+9.78%)

FNCH Finch Therapeutics
$2.47 /

+0.22 (+9.78%)

FNCH Finch Therapeutics
$2.47 /

+0.22 (+9.78%)

Recommendations
Tyson Foods price target lowered to $90 from $99 at BMO Capital » 06:16
08/09/22
08/09
06:16
08/09/22
06:16
TSN

Tyson Foods

$80.10 /

-7.395 (-8.45%)

BMO Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TSN Tyson Foods
$80.10 /

-7.395 (-8.45%)

TSN Tyson Foods
$80.10 /

-7.395 (-8.45%)

05:55 Today Barclays
Tyson Foods price target lowered to $89 from $100 at Barclays
04:57 Today Piper Sandler
Piper upgrades Tyson Foods to Neutral with risks priced in
08/08/22 Piper Sandler
Tyson Foods upgraded to Neutral from Underweight at Piper Sandler
07/20/22 Cleveland Research
Tyson Foods downgraded to Neutral from Buy at Cleveland Research
TSN Tyson Foods
$80.10 /

-7.395 (-8.45%)

TSN Tyson Foods
$80.10 /

-7.395 (-8.45%)

TSN Tyson Foods
$80.10 /

-7.395 (-8.45%)

TSN Tyson Foods
$80.10 /

-7.395 (-8.45%)

Recommendations
Signify Health, CVS deal could be 'win-win,' says Deutsche Bank » 06:16
08/09/22
08/09
06:16
08/09/22
06:16
SGFY

Signify Health

$22.06 /

+2.195 (+11.05%)

, CVS

CVS Health

$102.00 /

-0.34 (-0.33%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SGFY Signify Health
$22.06 /

+2.195 (+11.05%)

CVS CVS Health
$102.00 /

-0.34 (-0.33%)

SGFY Signify Health
$22.06 /

+2.195 (+11.05%)

08/08/22 Cowen
Signify Health price target raised to $24 from $14 at Cowen
08/08/22 BofA
CVS deal for Signify would help with continued evolution, says BofA
08/04/22 Piper Sandler
Signify Health price target raised to $34 from $32 at Piper Sandler
07/28/22 RBC Capital
Signify Health initiated with a Sector Perform at RBC Capital
CVS CVS Health
$102.00 /

-0.34 (-0.33%)

08/08/22 BofA
CVS deal for Signify would help with continued evolution, says BofA
08/04/22 Evercore ISI
CVS Health removed from 'TAP Outperform' list at Evercore ISI
08/04/22 Deutsche Bank
CVS Health price target raised to $120 from $113 at Deutsche Bank
07/21/22 Stifel
Logical to see Oak Street, Cano as 'in play' after 1Life deal, says Stifel
SGFY Signify Health
$22.06 /

+2.195 (+11.05%)

CVS CVS Health
$102.00 /

-0.34 (-0.33%)

SGFY Signify Health
$22.06 /

+2.195 (+11.05%)

CVS CVS Health
$102.00 /

-0.34 (-0.33%)

SGFY Signify Health
$22.06 /

+2.195 (+11.05%)

CVS CVS Health
$102.00 /

-0.34 (-0.33%)

CVS CVS Health
$102.00 /

-0.34 (-0.33%)

Hot Stocks
Louisiana-Pacific sees Q3 adjusted EBITDA $200M » 06:15
08/09/22
08/09
06:15
08/09/22
06:15
LPX

Louisiana-Pacific

$62.58 /

+1.175 (+1.91%)

Sees FY22 capital…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LPX Louisiana-Pacific
$62.58 /

+1.175 (+1.91%)

LPX Louisiana-Pacific
$62.58 /

+1.175 (+1.91%)

06/29/22 Truist
Louisiana-Pacific initiated with a Hold at Truist
06/23/22 TD Securities
Louisiana-Pacific price target lowered to $75 from $85 at TD Securities
06/23/22 BofA
Louisiana-Pacific downgraded to Neutral at BofA on housing slowdown
06/23/22 BofA
Louisiana-Pacific downgraded to Neutral from Buy at BofA
LPX Louisiana-Pacific
$62.58 /

+1.175 (+1.91%)

Earnings
Louisiana-Pacific reports Q2 adjusted EPS $4.19, consensus $4.40 » 06:15
08/09/22
08/09
06:15
08/09/22
06:15
LPX

Louisiana-Pacific

$62.58 /

+1.175 (+1.91%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LPX Louisiana-Pacific
$62.58 /

+1.175 (+1.91%)

LPX Louisiana-Pacific
$62.58 /

+1.175 (+1.91%)

06/29/22 Truist
Louisiana-Pacific initiated with a Hold at Truist
06/23/22 TD Securities
Louisiana-Pacific price target lowered to $75 from $85 at TD Securities
06/23/22 BofA
Louisiana-Pacific downgraded to Neutral at BofA on housing slowdown
06/23/22 BofA
Louisiana-Pacific downgraded to Neutral from Buy at BofA
LPX Louisiana-Pacific
$62.58 /

+1.175 (+1.91%)

Hot Stocks
Google back up after brief outage Monday night, says Downdetector » 06:14
08/09/22
08/09
06:14
08/09/22
06:14
GOOG

Alphabet

$118.17 /

-0.11 (-0.09%)

, GOOGL

Alphabet

$117.32 /

-0.17 (-0.14%)

Google services appear to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GOOG Alphabet
$118.17 /

-0.11 (-0.09%)

GOOGL Alphabet
$117.32 /

-0.17 (-0.14%)

GOOG Alphabet
$118.17 /

-0.11 (-0.09%)

08/03/22 Tigress Financial
Alphabet price target raised to $186 from $183 at Tigress Financial
07/27/22 Truist
Chrome cookie phase-out delay positive for Criteo, says Truist
07/27/22 KeyBanc
Google's cookie phase-out delay not surprising, says KeyBanc
07/27/22 RBC Capital
Google cookie phase-out delay adds another year of uncertainty, says RBC Capital
GOOGL Alphabet
$117.32 /

-0.17 (-0.14%)

08/03/22 Tigress Financial
Alphabet price target raised to $186 from $183 at Tigress Financial
07/27/22 Truist
Chrome cookie phase-out delay positive for Criteo, says Truist
07/27/22 KeyBanc
Google's cookie phase-out delay not surprising, says KeyBanc
07/27/22 RBC Capital
Google cookie phase-out delay adds another year of uncertainty, says RBC Capital
GOOG Alphabet
$118.17 /

-0.11 (-0.09%)

GOOGL Alphabet
$117.32 /

-0.17 (-0.14%)

GOOG Alphabet
$118.17 /

-0.11 (-0.09%)

GOOGL Alphabet
$117.32 /

-0.17 (-0.14%)

GOOG Alphabet
$118.17 /

-0.11 (-0.09%)

GOOGL Alphabet
$117.32 /

-0.17 (-0.14%)

GOOG Alphabet
$118.17 /

-0.11 (-0.09%)

GOOGL Alphabet
$117.32 /

-0.17 (-0.14%)

Earnings
Patria Investments reports Q2 EPS 20c, consensus 21c » 06:14
08/09/22
08/09
06:14
08/09/22
06:14
PAX

Patria Investments

$15.35 /

+0.35 (+2.33%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PAX Patria Investments
$15.35 /

+0.35 (+2.33%)

PAX Patria Investments
$15.35 /

+0.35 (+2.33%)

Recommendations
Keysight Technologies price target raised to $190 from $176 at Deutsche Bank » 06:13
08/09/22
08/09
06:13
08/09/22
06:13
KEYS

Keysight Technologies

$166.33 /

-0.99 (-0.59%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KEYS Keysight Technologies
$166.33 /

-0.99 (-0.59%)

KEYS Keysight Technologies
$166.33 /

-0.99 (-0.59%)

07/14/22 JPMorgan
Keysight Technologies price target lowered to $176 from $200 at JPMorgan
06/17/22 UBS
Keysight Technologies price target lowered to $177 from $220 at UBS
06/01/22 Goldman Sachs
Keysight Technologies price target lowered to $165 from $185 at Goldman Sachs
05/18/22 JPMorgan
Keysight Technologies price target lowered to $200 from $230 at JPMorgan
KEYS Keysight Technologies
$166.33 /

-0.99 (-0.59%)

KEYS Keysight Technologies
$166.33 /

-0.99 (-0.59%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.